| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$3 ) |
| | 2025 | 2023 | THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC | 80 PINE ST FL 20 | NEW YORK | NY | 10005-1702 | NEW YORK | USA | U19AI142735 | Modulation of Protein production and Degradation as an integrated approach to rapid sterilization of Drug sensitive and resistant Mtb. | 000 | 5 | NIH | 11/26/2024 | -$3 |
|
| Issue Date FY: 2023 ( Subtotal = $5,472,466 ) |
| | 2023 | 2023 | THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC | 40 WALL ST | NEW YORK | NY | 10005-1338 | NEW YORK | USA | U19AI142735 | Modulation of Protein production and Degradation as an integrated approach to rapid sterilization of Drug sensitive and resistant Mtb. | 000 | 5 | NIH | 3/13/2023 | $5,472,466 |
| | 2023 | 2023 | THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC | 40 WALL ST | NEW YORK | NY | 10005-1338 | NEW YORK | USA | U19AI142735 | Modulation of Protein production and Degradation as an integrated approach to rapid sterilization of Drug sensitive and resistant Mtb. | 001 | 5 | NIH | 3/24/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $5,956,416 ) |
| | 2022 | 2022 | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC., THE | 40 WALL ST FL 24 | NEW YORK | NY | 10005-1338 | NEW YORK | USA | U19AI142735 | Modulation of Protein production and Degradation as an integrated approach to rapid sterilization of Drug sensitive and resistant Mtb. | 000 | 4 | NIH | 3/22/2022 | $5,956,416 |
|
| Issue Date FY: 2021 ( Subtotal = $6,025,401 ) |
| | 2021 | 2021 | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC., THE | 40 WALL ST FL 24 | NEW YORK | NY | 10005-1338 | NEW YORK | USA | U19AI142735 | Modulation of Protein production and Degradation as an integrated approach to rapid sterilization of Drug sensitive and resistant Mtb. | 000 | 3 | NIH | 4/8/2021 | $6,025,401 |
|
| Issue Date FY: 2020 ( Subtotal = $5,528,394 ) |
| | 2020 | 2020 | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC., THE | 40 WALL ST FL 24 | NEW YORK | NY | 10005-1338 | NEW YORK | USA | U19AI142735 | Modulation of Protein production and Degradation as an integrated approach to rapid sterilization of Drug sensitive and resistant Mtb. | 000 | 2 | NIH | 3/31/2020 | $5,528,394 |
| | 2020 | 2020 | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC., THE | 40 WALL ST FL 24 | NEW YORK | NY | 10005-1338 | NEW YORK | USA | U19AI142735 | Modulation of Protein production and Degradation as an integrated approach to rapid sterilization of Drug sensitive and resistant Mtb. | 001 | 2 | NIH | 8/28/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $5,485,460 ) |
| | 2019 | 2019 | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC., THE | 40 WALL ST FL 24 | NEW YORK | NY | 10005-1338 | NEW YORK | USA | U19AI142735 | Modulation of Protein production and Degradation as an integrated approach to rapid sterilization of Drug sensitive and resistant Mtb. | 000 | 1 | NIH | 4/1/2019 | $5,485,460 |
|
| Issue Date FY: 2017 ( Subtotal = $0 ) |
| | 2017 | 2016 | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC., THE | 40 WALL ST FL 24 | NEW YORK | NY | 10005-1338 | NEW YORK | USA | R24AI100646 | Consortium for TB Biomarkers | 001 | 5 | NIH | 8/15/2017 | $0 |
| | 2017 | 2015 | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC., THE | 40 WALL ST FL 24 | NEW YORK | NY | 10005-1338 | NEW YORK | USA | R24AI100646 | Consortium for TB Biomarkers | 000 | 4 | NIH | 6/26/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $446,581 ) |
| | 2016 | 2016 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | R24AI100646 | Consortium for TB Biomarkers | 000 | 5 | NIH | 2/26/2016 | $446,581 |
|
| Issue Date FY: 2015 ( Subtotal = $446,946 ) |
| | 2015 | 2015 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | R24AI100646 | Consortium for TB Biomarkers | 000 | 4 | NIH | 2/5/2015 | $446,946 |
|
| Issue Date FY: 2014 ( Subtotal = $448,135 ) |
| | 2014 | 2014 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | R24AI100646 | Consortium for TB Biomarkers | 000 | 3 | NIH | 2/19/2014 | $448,135 |
| | 2014 | 2012 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | U18FD004004 | Qualifying New Pre-Clinical Models for the Develop. of Tuberculosis Drug | 000 | 3 | FDA | 12/31/2013 | $0 |
| | 2014 | 2012 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | U18FD004005 | Consortium for TB Biomarkers | 000 | 3 | FDA | 12/31/2013 | $0 |
|
| Issue Date FY: 2013 ( Subtotal = $422,979 ) |
| | 2013 | 2013 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | R24AI100646 | Consortium for TB Biomarkers | 001 | 2 | NIH | 8/8/2013 | $18,000 |
| | 2013 | 2013 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | R24AI100646 | Consortium for TB Biomarkers | 000 | 2 | NIH | 1/28/2013 | $404,979 |
| | 2013 | 2012 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | U18FD004004 | Qualifying New Pre-Clinical Models for the Develop. of Tuberculosis Drug | 000 | 3 | FDA | 11/26/2012 | $0 |
|
| Issue Date FY: 2012 ( Subtotal = $1,251,744 ) |
| | 2012 | 2012 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | R24AI100646 | Consortium for TB Biomarkers | 000 | 1 | NIH | 3/8/2012 | $451,744 |
| | 2012 | 2012 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | U18FD004004 | Qualifying New Pre-Clinical Models for the Develop. of Tuberculosis Drug | 002 | 3 | FDA | 8/31/2012 | $400,000 |
| | 2012 | 2012 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | U18FD004005 | Consortium for TB Biomarkers | 002 | 3 | FDA | 8/31/2012 | $400,000 |
| | 2012 | 2011 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | U18FD004005 | Consortium for TB Biomarkers | 001 | 2 | FDA | 8/30/2012 | $0 |
| | 2012 | 2011 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | U18FD004005 | Consortium for TB Biomarkers | 000 | 2 | FDA | 12/21/2011 | $0 |
| | 2012 | 2011 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | U18FD004004 | Qualifying New Pre-Clinical Models for the Develop. of Tuberculosis Drug | 001 | 2 | FDA | 8/22/2012 | $0 |
| | 2012 | 2011 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | U18FD004004 | Qualifying New Pre-Clinical Models for the Develop. of Tuberculosis Drug | 000 | 2 | FDA | 8/20/2012 | $0 |
|
| Issue Date FY: 2011 ( Subtotal = $594,859 ) |
| | 2011 | 2011 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | U18FD004004 | Qualifying New Pre-Clinical Models for the Develop. of Tuberculosis Drug | 001 | 2 | FDA | 9/19/2011 | $249,616 |
| | 2011 | 2011 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | U18FD004005 | Consortium for TB Biomarkers | 001 | 2 | FDA | 9/19/2011 | $345,243 |
| | 2011 | 2010 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | U18FD004005 | Consortium for TB Biomarkers | 000 | 1 | FDA | 9/15/2011 | $0 |
| | 2011 | 2010 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | U18FD004004 | Qualifying New Pre-Clinical Models for the Develop. of Tuberculosis Drug | 000 | 1 | FDA | 9/15/2011 | $0 |
|
| Issue Date FY: 2010 ( Subtotal = $1,207,734 ) |
| | 2010 | 2010 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | U18FD004005 | Consortium for TB Biomarkers | 000 | 1 | FDA | 9/17/2010 | $680,000 |
| | 2010 | 2010 | Global Alliance for TB Drug Development | 40 Wall Street, 24th Floor | MANHATTAN | NY | 10005 | NEW YORK | USA | U18FD004004 | Qualifying New Pre-Clinical Models for the Develop. of Tuberculosis Drug | 000 | 1 | FDA | 9/17/2010 | $527,734 |
|
|
